SCHEMBL9217894

SCHEMBL9217894

CCOC(=O)N1CCC(C=O)C1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.51
L3MBTL1 Q9Y468 4/20 0.47
THRB P10828 1/20 0.47
ATM Q13315 1/20 0.47
NOS3 P29474 1/20 0.45
NOS2 P35228 1/20 0.45
ALDH1A1 P00352 4/20 0.45
CHRM1 P11229 1/20 0.44
TSHR P16473 1/20 0.43
POLB P06746 2/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 3/20 0.41
PKM P14618 1/20 0.41
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4713526 0.90 ALDH1A1 (0.46) GAAL3MBTL1THRBATMNOS3
SCHEMBL1267031 0.89 GAA (0.59) GAAL3MBTL1THRBATMNOS3
SCHEMBL28344159 0.89 GAA (0.42) GAAL3MBTL1THRBATMNOS3
SCHEMBL12468367 0.86 SMN1; SMN2 (0.50) GAAL3MBTL1THRBATMNOS3
SCHEMBL12468857 0.86 SMN1; SMN2 (0.50) GAAL3MBTL1THRBATMNOS3
SCHEMBL3830772 0.84 RAB9A (0.44) GAAL3MBTL1THRBATMNOS3
SCHEMBL28038322 0.83 GAA (0.53) GAAL3MBTL1THRBATMNOS3
SCHEMBL5006363 0.82 CHRNB2 (0.42) L3MBTL1TSHRSMN1; SMN2
SCHEMBL9193650 0.82 GPR119 (0.39) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL30885572 0.81 GAA (0.46) GAAL3MBTL1THRBATMNOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113272309-B Tricyclic inhibitors of hepatitis b virus 圣拉斐尔医院有限公司 2024-02-23 CN disclosed
EP-3287461-A1 IMIDAZO ISOINDOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Hengrui Medicine Co., Ltd. (CN) 2018-02-28 EP disclosed
EP-0320032-B1 Pyridizinamine derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-01-18 EP disclosed
US-5231184-A Viricide intermediate JANSSEN PHARMACEUTICA N.V. (BE) 1993-07-27 US disclosed
US-5106973-A Viricide intermediates JANSSEN PHARMACEUTICA N.V. (BE) 1992-04-21 US disclosed
US-4992433-A Viricides JANSSEN PHARMACEUTICA N.V. (BE) 1991-02-12 US disclosed
US-4992534-A Anticarcinogenic agents with better water solubility, low toxicity, absorption and stability OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-02-12 US disclosed
EP-0320032-A1 Pyridizinamine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1989-06-14 EP disclosed
EP-0303269-A2 2'-Deoxy-5-fluorouridine derivatives, process for preparing the same and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-02-15 EP disclosed